Bio-Path Holdings Inc Share Price Nasdaq
Equities
US09057N1028
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.16M 347M |
---|---|---|---|---|---|
Net income 2024 * | -12M -1B | Net income 2025 * | -13M -1.08B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.14
x | P/E ratio 2025 * |
-0.14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Bio-Path Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 10/07/10 | |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 10/07/10 |
Douglas Morris
FOU | Founder | 68 | 10/07/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Morris
FOU | Founder | 68 | 10/07/10 |
Heath Cleaver
BRD | Director/Board Member | 51 | 11/14/11 |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 10/07/10 |
1st Jan change | Capi. | |
---|---|---|
+23.77% | 48.09B | |
+47.41% | 40.62B | |
-3.17% | 40.43B | |
-6.20% | 28.36B | |
+7.53% | 24.89B | |
-19.26% | 19.01B | |
+29.87% | 12.09B | |
-0.78% | 11.88B | |
+0.01% | 11.8B |